These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2926043)

  • 41. Significance of ventricular arrhythmias initiated by programmed ventricular stimulation: the importance of the type of ventricular arrhythmia induced and the number of premature stimuli required.
    Brugada P; Green M; Abdollah H; Wellens HJ
    Circulation; 1984 Jan; 69(1):87-92. PubMed ID: 6689650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation.
    Roden DM; Lee JT; Woosley RL; Echt DS
    Circulation; 1989 Nov; 80(5):1247-58. PubMed ID: 2805262
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Surgical decisions in the management of sudden cardiac death and malignant ventricular arrhythmias. Subendocardial resection, the automatic internal defibrillator, or both.
    Hargrove WC; Josephson ME; Marchlinski FE; Miller JM
    J Thorac Cardiovasc Surg; 1989 Jun; 97(6):923-8. PubMed ID: 2724998
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ventricular tachycardia and ventricular fibrillation in a young population.
    Pedersen DH; Zipes DP; Foster PR; Troup PJ
    Circulation; 1979 Nov; 60(5):988-97. PubMed ID: 487557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of malignant ventricular arrhythmias and cardiac arrest.
    Fogel RI; Prystowsky EN
    Crit Care Med; 2000 Oct; 28(10 Suppl):N165-9. PubMed ID: 11055686
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Electrophysiologic and antiarrhythmic efficacy of oral sotalol for sustained ventricular tachyarrhythmias: evaluation by programmed stimulation and ambulatory electrocardiogram.
    Steinbeck G; Bach P; Haberl R
    J Am Coll Cardiol; 1986 Oct; 8(4):949-58. PubMed ID: 3760368
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias.
    Tchou PJ; Kadri N; Anderson J; Caceres JA; Jazayeri M; Akhtar M
    Ann Intern Med; 1988 Oct; 109(7):529-34. PubMed ID: 3262325
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.
    Heger JJ; Prystowsky EN; Zipes DP
    Am Heart J; 1983 Oct; 106(4 Pt 2):887-94. PubMed ID: 6613835
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
    Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
    N Engl J Med; 1997 Nov; 337(22):1576-83. PubMed ID: 9411221
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Low energy cardioversion with the implantable cardioversion defibrillator devices for treatment of ventricular tachycardia and ventricular fibrillation].
    Siebels J; Schneider MA; Kuck KH
    Z Kardiol; 1993 Nov; 82(11):683-91. PubMed ID: 8291289
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proarrhythmic responses during electrophysiologic testing.
    Horowitz LN; Greenspan AM; Rae AP; Kay HR; Spielman SR
    Am J Cardiol; 1987 Apr; 59(11):45E-48E. PubMed ID: 3578040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment of malignant ventricular tachyarrhythmia with amiodarone: comparison of empirical administration and administration guided by Holter or ventricular stimulation. Results of the parallel test].
    Raviele A; Di Pede F; Gasparini G; Zanocco A; Delise P; Bonso A; D'Este D; Piccolo E
    G Ital Cardiol; 1991 Mar; 21(3):259-69. PubMed ID: 1894120
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polymorphous ventricular tachycardia: clinical features and treatment.
    Sclarovksy S; Strasberg B; Lewin RF; Agmon J
    Am J Cardiol; 1979 Aug; 44(2):339-44. PubMed ID: 463773
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
    Raviele A; Di Pede F; Delise P; Piccolo E
    G Ital Cardiol; 1984 Sep; 14(9):644-54. PubMed ID: 6510619
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator.
    Skowasch D; Ringquist S; Nickenig G; Andrié R
    PLoS One; 2018; 13(3):e0194496. PubMed ID: 29566033
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Radiofrequency catheter ablation of sustained ventricular tachycardia in idiopathic dilated cardiomyopathy.
    Kottkamp H; Hindricks G; Chen X; Brunn J; Willems S; Haverkamp W; Block M; Breithardt G; Borggrefe M
    Circulation; 1995 Sep; 92(5):1159-68. PubMed ID: 7648661
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Repetitive ventricular response by programmed electrostimulation of the heart: frequency and clinical significance].
    Meinertz T; Treese N; Kasper W; Pop T
    Herz; 1984 Feb; 9(1):34-44. PubMed ID: 6706284
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications.
    Orgeron GM; James CA; Te Riele A; Tichnell C; Murray B; Bhonsale A; Kamel IR; Zimmerman SL; Judge DP; Crosson J; Tandri H; Calkins H
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588093
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Myocardial revascularization in malignant ventricular tachyarrhythmia--prognostic significance].
    Pleskot M; Parízek P; Hodac M; Haman L; St'ásek J; Cervinka P; Tauchman M
    Cas Lek Cesk; 2000 Jan; 139(1):13-7. PubMed ID: 10750286
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ventricular arrhythmias: medical therapy, device treatment, and indications for electrophysiologic study.
    Sager PT; Batsford WP
    Cardiol Clin; 1988 Feb; 6(1):37-47. PubMed ID: 3048673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.